BACKGROUND AND PURPOSE: Age related white matter changes (ARWMC) are frequent in non-demented old subjects and are associated with impaired cognitive function. Our aim was to study the influence of vascular risk factors and ARWMC on the neuropsychological performance of an independent elderly population, to see if vascular risk factors impair cognition in addition to the effects of ARWMC. METHODS: Independent subjects, aged 65-84 years, with any degree of ARWMC were assessed using a comprehensive neuropsychological battery including the Mini-Mental State Examination (MMSE), VADAS-Cog (Alzheimer's disease assessment scale) and the Stroop and Trail Making test. Vascular risk factors were recorded and ARWMC (measured by MRI) were graded into three classes. The impact of vascular risk factors and ARWMC on neuropsychological performance was assessed by linear regression analyses, with adjustment for age and education. RESULTS: 638 patients (74.1 (5) years old, 55% women) were included. Patients with severe ARWMC performed significantly worse on global tests of cognition, executive functions, speed and motor control, attention, naming and visuoconstructional praxis. Diabetes interfered with tests of executive function, attention, speed and motor control, memory and naming. Arterial hypertension and stroke influenced executive functions and attention. The effect of these vascular risk factors was independent of the severity of ARWMC, age and education. CONCLUSION: ARWMC is related to worse performance in executive function, attention and speed. Diabetes, hypertension and previous stroke influenced neuropsychological performance, independently of the severity of ARWMC, stressing the need to control vascular risk factors in order to prevent cognitive decline in the elderly.
BACKGROUND AND PURPOSE: Age related white matter changes (ARWMC) are frequent in non-demented old subjects and are associated with impaired cognitive function. Our aim was to study the influence of vascular risk factors and ARWMC on the neuropsychological performance of an independent elderly population, to see if vascular risk factors impair cognition in addition to the effects of ARWMC. METHODS: Independent subjects, aged 65-84 years, with any degree of ARWMC were assessed using a comprehensive neuropsychological battery including the Mini-Mental State Examination (MMSE), VADAS-Cog (Alzheimer's disease assessment scale) and the Stroop and Trail Making test. Vascular risk factors were recorded and ARWMC (measured by MRI) were graded into three classes. The impact of vascular risk factors and ARWMC on neuropsychological performance was assessed by linear regression analyses, with adjustment for age and education. RESULTS: 638 patients (74.1 (5) years old, 55% women) were included. Patients with severe ARWMC performed significantly worse on global tests of cognition, executive functions, speed and motor control, attention, naming and visuoconstructional praxis. Diabetes interfered with tests of executive function, attention, speed and motor control, memory and naming. Arterial hypertension and stroke influenced executive functions and attention. The effect of these vascular risk factors was independent of the severity of ARWMC, age and education. CONCLUSION:ARWMC is related to worse performance in executive function, attention and speed. Diabetes, hypertension and previous stroke influenced neuropsychological performance, independently of the severity of ARWMC, stressing the need to control vascular risk factors in order to prevent cognitive decline in the elderly.
Authors: W T Longstreth; T A Manolio; A Arnold; G L Burke; N Bryan; C A Jungreis; P L Enright; D O'Leary; L Fried Journal: Stroke Date: 1996-08 Impact factor: 7.914
Authors: F E de Leeuw; J C de Groot; E Achten; M Oudkerk; L M Ramos; R Heijboer; A Hofman; J Jolles; J van Gijn; M M Breteler Journal: J Neurol Neurosurg Psychiatry Date: 2001-01 Impact factor: 10.154
Authors: Annemieke Ruitenberg; John C van Swieten; Jacqueline C M Witteman; Kala M Mehta; Cornelia M van Duijn; Albert Hofman; Monique M B Breteler Journal: Lancet Date: 2002-01-26 Impact factor: 79.321
Authors: J C van Swieten; G G Geyskes; M M Derix; B M Peeck; L M Ramos; J C van Latum; J van Gijn Journal: Ann Neurol Date: 1991-12 Impact factor: 10.422
Authors: Emma J Burton; Rose Anne Kenny; John O'Brien; Sally Stephens; Michael Bradbury; Elise Rowan; Raj Kalaria; Michael Firbank; Keith Wesnes; Clive Ballard Journal: Stroke Date: 2004-04-29 Impact factor: 7.914
Authors: Anna Maria Basile; Leonardo Pantoni; Giovanni Pracucci; Kjell Asplund; Hugues Chabriat; Timo Erkinjuntti; Franz Fazekas; José M Ferro; Michael Hennerici; John O'Brien; Philip Scheltens; Marieke C Visser; Lars-Olof Wahlund; Gunhild Waldemar; Anders Wallin; Domenico Inzitari Journal: Cerebrovasc Dis Date: 2006-02-14 Impact factor: 2.762
Authors: Heidi I L Jacobs; Elizabeth C Leritz; Victoria J Williams; Martin P J Van Boxtel; Wim van der Elst; Jelle Jolles; Frans R J Verhey; Regina E McGlinchey; William P Milberg; David H Salat Journal: Hum Brain Mapp Date: 2011-09-23 Impact factor: 5.038
Authors: James A Mortimer; Amy R Borenstein; Ding Ding; Charles Decarli; Qianhua Zhao; Cathleen Copenhaver; Qihao Guo; Shugang Chu; Douglas Galasko; David P Salmon; Qi Dai; Yougui Wu; Ronald Petersen; Zhen Hong Journal: Alzheimers Dement Date: 2010-11 Impact factor: 21.566
Authors: Kazuhide Hayakawa; Nobukazu Miyamoto; Ji Hae Seo; Loc-Duyen D Pham; Kyu-Won Kim; Eng H Lo; Ken Arai Journal: J Neurochem Date: 2012-12-28 Impact factor: 5.372
Authors: S D Israeli-Korn; M Masarwa; E Schechtman; A Abuful; R Strugatsky; S Avni; L A Farrer; R P Friedland; R Inzelberg Journal: Neuroepidemiology Date: 2009-12-11 Impact factor: 3.282